POPULATION PHARMACOKINETIC AND EXPOSURE-RESPONSE ANALYSES OF A PHASE 1 STUDY OF SUTIMLIMAB IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA.

被引：0
|
作者：
Chow, T. [1 ]
Daak, A. [1 ]
Lu, Q. [2 ]
Wong, N. [1 ]
机构：
[1] Sanofi, Waltham, MA USA
[2] Sanofi, Bridgewater, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P-038
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetic and Exposure-Response Analyses for Ponatinib in the Phase 3 PhALLCON Study
    Hanley, Michael J.
    Larson, Thomas R.
    Diderichsen, Paul M.
    Largajolli, Anna
    Hui, Katrina
    Srimani, Jaydeep
    Wang, Bingxia
    Vorog, Alexander
    Gupta, Neeraj
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (03):
  • [2] Population pharmacokinetic and exposure-response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
    Gibiansky, Ekaterina
    Gibiansky, Leonid
    Chavanne, Clarisse
    Frey, Nicolas
    Jamois, Candice
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 914 - 927
  • [3] Population pharmacokinetic and exposure-response analyses of guanfacine in Japanese pediatric ADHD patients
    Tsuda, Yoshiyuki
    Matsuo, Yumiko
    Matsumoto, Sayaka
    Wajima, Toshihiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (06) : 365 - 371
  • [4] Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia
    Darstein, Christelle
    Yoon, Deokyong
    Yang, Yiqun
    Kapoor, Shruti
    Dasgupta, Kohinoor
    Wu, Shengyuan
    Kawakita, Yasunori
    Hoch, Matthias
    Grosch, Kai
    Sy, Sherwin K. B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [5] Adjunctive Perampanel In Paediatric Patients With Epilepsy: Population Pharmacokinetic (PK) And Exposure-Response Analyses
    Majid, O.
    Reyderman, L.
    Ferry, J.
    Hussein, Z.
    EPILEPSIA, 2019, 60 : 107 - 108
  • [6] Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses
    Majid, Oneeb
    Reyderman, Larisa
    Ferry, Jim
    Hussein, Ziad
    NEUROLOGY, 2019, 92 (15)
  • [7] PHASE 2 CONCIZUMAB POPULATION PHARMACOKINETIC AND EXPOSURE-RESPONSE ANALYSES: APPLICATION TO PHASE 3 DOSE SELECTION
    Rose, T. H.
    Hollensen, C.
    Agerso, H.
    Ingwersen, S. H.
    Overgaard, R. V.
    HAEMOPHILIA, 2020, 26 : 127 - 128
  • [8] Population Pharmacokinetic and Exposure-Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia
    Moser, Brian A.
    LaBell, Elizabeth S.
    Chigutsa, Emmanuel
    Jakubowski, Joseph A.
    Small, David S.
    CLINICAL PHARMACOKINETICS, 2018, 57 (02) : 243 - 254
  • [9] Population pharmacokinetic and exposure-response analyses of ivosidenib in patients with IDH1-mutant advanced hematologic malignancies
    Jiang, Xuemin
    Wada, Russ
    Poland, Bill
    Kleijn, Huub Jan
    Fan, Bin
    Liu, Guowen
    Liu, Hua
    Kapsalis, Stephanie
    Yang, Hua
    Le, Kha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (03): : 942 - 953
  • [10] Population pharmacokinetic and exposure-response analyses to support fixed dosing of tezepelumab in patients with severe asthma
    Zheng, Yanan
    Guan, Ye
    Gao, Yuying
    Liu, Lu
    Abuqayyas, Lubna
    Hellqvist, Asa
    Bowen, Karin
    Colice, Gene
    Macdonald, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345